Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials
Jeremy M. O'Connor, Kristen L. Fessele, Jean Steiner, Kathi Seidl-Rathkopf, Kenneth R. Carson, Nathan C. Nussbaum, Emily S. Yin, Kerin B. Adelson, Carolyn J. Presley, Anne C. Chiang, Joseph S. Ross, Amy P. Abernethy, Cary P. Gross*
Dive into the research topics of 'Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials'. Together they form a unique fingerprint.